Atkore announces acquisition of Rocky Mountain Colby Pipe Co. assets
By Nikita Chaurasia  Date: 2019-08-23

Atkore announces acquisition of Rocky Mountain Colby Pipe Co. assets

Atkore expands product portfolio with acquisition of Cor-Tek™ by Rocky Mountain 

Atkore International Group Inc., a US-based electric solutions provider recently announced acquisition of assets of Rocky Mountain Colby Pipe Co., a front-runner in PVC conduit & duct products that are being sold under the brand name Cor-Tek™. Terms and conditions related to the transaction are kept undisclosed, report sources.

For the record, Atkore International Group has an exclusive portfolio of integrated electrical solutions and offers a complete line of PVC conduit & duct products that are available in one-half inch through 8-inch diameters & in ten-foot and twenty-foot lengths that meet NEMA, ASTM and UL specifications.

With 66 manufacturing & distribution facilities worldwide along with 3,975 employees, the company meets customer requirements by providing unmatched value, quality & delivery across a wide product line that includes aluminum and PVC conduit, steel, armored cable & flexible conduits, wire baskets, metal framing, cable trays and other complementary products including mechanical tube and fittings.

Rocky Mountain Colby Pipe Co. is an innovator among PVC pipe extruders in North America that is focused on cellular core extrusion technology. The company’s new manufacturing facility in Pendleton is the most advanced computerized PVC conduit & duct plant in the North America.

Rocky Mountain Colby Pipe is headquartered in Oregon and will continue to operate at its current location.

John Pregenzer, President, Conduit & Fittings business, Atkore, was reportedly quoted saying that Cor-Tek™ specializes in cellular core technology that delivers value & cost effectiveness to the commercial, industrial and residential electrical markets.

He added that this acquisition has better positioned the firm to focus on strategic growth by expanding the firm’s product portfolio along with improving geographic coverage for the West Coast, which will allow Atkore to meet customer needs.

Source credits: http://investors.atkore.com/news-releases/2019/08-22-2019-005322513

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...